Deborah Siegal/LinkedIn
Mar 1, 2026, 10:31
Deborah Siegal Explores ARTESiA in The CLOT Conversation’s Latest Episode
Thrombosis Canada shared on LinkedIn:
”Major bleeding remains the leading complication of oral anticoagulation.
In our latest episode of CLOT Conversations, Dr. Deborah Siegal discusses the ARTESiA subanalysis examining major bleeding with apixaban versus aspirin in patients with device-detected subclinical atrial fibrillation.
Key insights:
- Apixaban reduced stroke/systemic embolism by 37%
- Major bleeding increased, largely driven by gastrointestinal events
- Intracranial and fatal bleeding rates were low and similar
- Most bleeding events were not clinical emergencies
- NSAID use emerged as a key modifiable risk factor
Understanding not just how often bleeding occurs, but how severe it is, is critical to individualized risk assessment and shared decision-making.”
Stay updated with Hemostasis Today.
-
Jul 18, 2026, 14:50Nikola Pantic: Grateful for the People Who Made ISTH 2026 Special
-
Jul 18, 2026, 14:30Denise Rezende: Werfen Reflects on a Successful ISTH 2026 Congress
-
Jul 18, 2026, 14:28Isabelle Salles-Crawley: Science, Collaboration, and Inspiration at ISTH 2026
-
Jul 18, 2026, 14:05Habib Bennaceur: Novo Nordisk Highlights Progress in Rare Bleeding Disorders at ISTH 2026
-
Jul 18, 2026, 13:56C. Heleen van Ommen: IPTN Meeting Highlights Progress in Pediatric Thrombosis
-
Jul 18, 2026, 13:42Chokri Ben Lamine: Optimizing PBSC Donation in Hemoglobinopathy Carriers
-
Jul 18, 2026, 12:17Doruntina Lahu: Prasugrel and Ticagrelor – Does Sex Matter?
-
Jul 18, 2026, 11:54Paul Riley: Presenting STAR Max3 at ISTH 2026
-
Jul 18, 2026, 11:38Abdul Mannan: Normal Blood DEB Test Does Not Always Rule Out Fanconi Anaemia